|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/395 | |
| A61K 31/5377 | |||
| A61K 39/395 |
| (11) | Number of the document | 2370103 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09756754.9 |
| Date of filing the European patent application | 2009-11-25 | |
| (97) | Date of publication of the European application | 2011-10-05 |
| (45) | Date of publication and mention of the grant of the patent | 2016-03-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2009/065861 |
| Date | 2009-11-25 |
| (87) | Number | WO 2010/060939 |
| Date | 2010-06-03 |
| (30) | Number | Date | Country code |
| 08170255 | 2008-11-28 | EP | |
| 08170261 | 2008-11-28 | EP |
| (72) |
GARCIA-ECHEVERRIA, Carlos, CH
JENSEN, Michael, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMBINATIONS COMPRISING AN ISOXAZOLE DERIVED HSP90-INHIBITOR AND THE HER2 INHIBITOR TRASTUZUMAB |
| PHARMACEUTICAL COMBINATIONS COMPRISING AN ISOXAZOLE DERIVED HSP90-INHIBITOR AND THE HER2 INHIBITOR TRASTUZUMAB |